Exact Mass: 420.2285
Exact Mass Matches: 420.2285
Found 183 metabolites which its exact mass value is equals to given mass value 420.2285
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Levocabastine
Levocabastine is only found in individuals that have used or taken this drug. It is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.Levocabastine is a potent, selective histamine H1-receptor antagonist. It works by competing with histamine for H1-receptor sites on effector cells. It thereby prevents, but does not reverse, responses mediated by histamine alone. Levocabastine does not block histamine release but, rather, prevents histamine binding and activity. Levocabastine also binds neurotensin 2 receptors and serves as a neurotensin agonist. This can induce some degree of analgesia. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
(8alpha,10alpha,13alpha,17beta)-17-[(4-Hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
Cabastine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
Hexoprenaline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents
8-(3-(1-((3-Fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6-tetrahydro-4h-pyrrolo(3,2,1-ij)quinolin-4-one
8-[3-[1-[(3-Fluorophenyl)methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline-4-one
3-oxo-14,3-oxy-3(4->18)-abeo-brevia-1,4(18),12,2,4-pentaene 1,5-lactone|brevione C
3-hydroxy-24-methyl-25-oxo-hexacosa-5,7,9,11,13,15,17,19,21,23-decaenoic acid|laetiporic acid
(2E,4E)-cyclo-[(NMe-L-Ala)-(NMe-L-Val)-(Nalpha-6-oxohexa-2,4-dienoyl-L-Orn)]|sclerotiotide F
Ala Ala Phe Ile
Ala Ala Phe Leu
Ala Ala Ile Phe
Ala Ala Leu Phe
Ala Phe Ala Ile
Ala Phe Ala Leu
Ala Phe Ile Ala
Ala Phe Leu Ala
Ala Ile Ala Phe
Ala Ile Phe Ala
Ala Leu Ala Phe
Ala Leu Phe Ala
Phe Ala Ala Ile
Phe Ala Ala Leu
Phe Ala Ile Ala
Phe Ala Leu Ala
Phe Gly Val Val
Phe Ile Ala Ala
Phe Leu Ala Ala
Phe Val Gly Val
Phe Val Val Gly
Gly Phe Val Val
Gly Val Phe Val
Gly Val Val Phe
Ile Ala Ala Phe
Ile Ala Phe Ala
Ile Phe Ala Ala
Ile Ser Thr Thr
Ile Thr Ser Thr
Ile Thr Thr Ser
Leu Ala Ala Phe
Leu Ala Phe Ala
Leu Phe Ala Ala
Leu Ser Thr Thr
Leu Thr Ser Thr
Leu Thr Thr Ser
Ser Ile Thr Thr
Ser Leu Thr Thr
Ser Thr Ile Thr
Ser Thr Leu Thr
Ser Thr Thr Ile
Ser Thr Thr Leu
Thr Ile Ser Thr
Thr Ile Thr Ser
Thr Leu Ser Thr
Thr Leu Thr Ser
Thr Ser Ile Thr
Thr Ser Leu Thr
Thr Ser Thr Ile
Thr Ser Thr Leu
Thr Thr Ile Ser
Thr Thr Leu Ser
Thr Thr Ser Ile
Thr Thr Ser Leu
Thr Thr Thr Val
Thr Thr Val Thr
Thr Val Thr Thr
Val Phe Gly Val
Val Phe Val Gly
Val Gly Phe Val
Val Gly Val Phe
Val Thr Thr Thr
Val Val Phe Gly
Val Val Gly Phe
Cabastine
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
1-BOC-4-(2-CBZ-AMINO-2-METHOXYCARBONYL-ETHYL)PIPERIDINE
13-cis-12-(3-Carboxyphenyl)retinoic acid
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
(8alpha,10alpha,13alpha,17beta)-17-[(4-Hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
Hexoprenaline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents